Literature DB >> 15834428

Lactadherin promotes VEGF-dependent neovascularization.

Jean-Sébastien Silvestre1, Clotilde Théry, Ghislaine Hamard, Jacques Boddaert, Barbara Aguilar, Alain Delcayre, Christophe Houbron, Radia Tamarat, Olivier Blanc-Brude, Sylvia Heeneman, Michel Clergue, Micheline Duriez, Régine Merval, Bernard Lévy, Alain Tedgui, Sebastian Amigorena, Ziad Mallat.   

Abstract

Vascular endothelial growth factor (VEGF)-induced blood vessel growth is involved in both physiological and pathological angiogenesis and requires integrin-mediated signaling. We now show that an integrin-binding protein initially described in milk-fat globule, MFG-E8 (also known as lactadherin), is expressed in and around blood vessels and has a crucial role in VEGF-dependent neovascularization in the adult mouse. Using neutralizing antibodies and lactadherin-deficient animals, we show that lactadherin interacts with alphavbeta3 and alphavbeta5 integrins and alters both VEGF-dependent Akt phosphorylation and neovascularization. In the absence of VEGF, lactadherin administration induced alphavbeta3- and alphavbeta5-dependent Akt phosphorylation in endothelial cells in vitro and strongly improved postischemic neovascularization in vivo. These results show a crucial role for lactadherin in VEGF-dependent neovascularization and identify lactadherin as an important target for the modulation of neovascularization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15834428     DOI: 10.1038/nm1233

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  115 in total

1.  A role for activated endothelial cells in red blood cell clearance: implications for vasopathology.

Authors:  Marcel H A M Fens; Richard van Wijk; Grietje Andringa; Karlijn L van Rooijen; Hilde M Dijstelbloem; Jan T Rasmussen; Karen M K de Vooght; Raymond M Schiffelers; Carlo A J M Gaillard; Wouter W van Solinge
Journal:  Haematologica       Date:  2011-11-18       Impact factor: 9.941

2.  Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions.

Authors:  Patricia Rueda; Adèle Richart; Alice Récalde; Pamela Gasse; José Vilar; Coralie Guérin; Hugues Lortat-Jacob; Paulo Vieira; Franoise Baleux; Fabrice Chretien; Fernando Arenzana-Seisdedos; Jean-Sébastien Silvestre
Journal:  Circulation       Date:  2012-10-03       Impact factor: 29.690

3.  Protective effect of MFG-E8 after cutaneous ischemia-reperfusion injury.

Authors:  Akihiko Uchiyama; Kazuya Yamada; Buddhini Perera; Sachiko Ogino; Yoko Yokoyama; Yuko Takeuchi; Osamu Ishikawa; Sei-Ichiro Motegi
Journal:  J Invest Dermatol       Date:  2014-12-10       Impact factor: 8.551

4.  Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.

Authors:  Matthias Canault; Aurélie S Leroyer; Franck Peiretti; Guy Lesèche; Alain Tedgui; Bernadette Bonardo; Marie-Christine Alessi; Chantal M Boulanger; Gilles Nalbone
Journal:  Am J Pathol       Date:  2007-09-14       Impact factor: 4.307

5.  MFGE8 inhibits inflammasome-induced IL-1β production and limits postischemic cerebral injury.

Authors:  Nicolas Deroide; Xuan Li; Dominique Lerouet; Emily Van Vré; Lauren Baker; James Harrison; Marine Poittevin; Leanne Masters; Lina Nih; Isabelle Margaill; Yoichiro Iwakura; Bernhard Ryffel; Marc Pocard; Alain Tedgui; Nathalie Kubis; Ziad Mallat
Journal:  J Clin Invest       Date:  2013-02-01       Impact factor: 14.808

6.  Maternal environment interacts with modifier genes to influence progression of nephrotic syndrome.

Authors:  Julien Ratelade; Tiphaine Aguirre Lavin; Andrea Onetti Muda; Ludivine Morisset; Géraldine Mollet; Olivia Boyer; Deborah S Chen; Anna Henger; Matthias Kretzler; Norbert Hubner; Clotilde Théry; Marie-Claire Gubler; Xavier Montagutelli; Corinne Antignac; Ernie L Esquivel
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

7.  MFG-E8 Drives Melanoma Growth by Stimulating Mesenchymal Stromal Cell-Induced Angiogenesis and M2 Polarization of Tumor-Associated Macrophages.

Authors:  Kazuya Yamada; Akihiko Uchiyama; Akihito Uehara; Buddhini Perera; Sachiko Ogino; Yoko Yokoyama; Yuko Takeuchi; Mark C Udey; Osamu Ishikawa; Sei-Ichiro Motegi
Journal:  Cancer Res       Date:  2016-05-17       Impact factor: 12.701

8.  Correction of MFG-E8 Resolves Inflammation and Promotes Cutaneous Wound Healing in Diabetes.

Authors:  Amitava Das; Subhadip Ghatak; Mithun Sinha; Scott Chaffee; Noha S Ahmed; Narasimham L Parinandi; Eric S Wohleb; John F Sheridan; Chandan K Sen; Sashwati Roy
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

9.  Comparative proteomic analysis of normal and collagen IX null mouse cartilage reveals altered extracellular matrix composition and novel components of the collagen IX interactome.

Authors:  Bent Brachvogel; Frank Zaucke; Keyur Dave; Emma L Norris; Jacek Stermann; Münire Dayakli; Manuel Koch; Jeffrey J Gorman; John F Bateman; Richard Wilson
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

10.  Milk fat globule protein epidermal growth factor-8: a pivotal relay element within the angiotensin II and monocyte chemoattractant protein-1 signaling cascade mediating vascular smooth muscle cells invasion.

Authors:  Zongming Fu; Mingyi Wang; Marjan Gucek; Jing Zhang; James Wu; Liqun Jiang; Robert E Monticone; Benjamin Khazan; Richard Telljohann; Julie Mattison; Simon Sheng; Robert N Cole; Gaia Spinetti; Gianfranco Pintus; Lijuan Liu; Frank D Kolodgie; Renu Virmani; Harold Spurgeon; Donald K Ingram; Allen D Everett; Edward G Lakatta; Jennifer E Van Eyk
Journal:  Circ Res       Date:  2009-05-14       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.